Applying pGz in Mitochondrial Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Applying pGz in Mitochondrial Disease — Stella

Home/Mitochondrial Myopathies/

View on ClinicalTrials.gov

Recruiting

Back to Mitochondrial Myopathies trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Key details

Phase

Early testing

Sponsor

Children's Hospital of Philadelphia

Collaborators

United States Department of Defense

Enrollment target

~90 participants

Started

March 2023

Primary completion

September 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

10 Years – 60 Years

Last updated November 2025